Key result
Routine statin therapy cannot yet be recommended for all heart failure patients irrespective of aetiology due to small sample sizes and short follow-up in existing trials.
Why the study?
Should statins be routinely recommended for all patients with heart failure, irrespective of aetiology?
Should statins be routinely recommended for all patients with heart failure, irrespective of aetiology?
Answers are grounded in this paper and cite their sources.
The routine use of statins in all heart failure patients, regardless of etiology, is not currently recommended.
Although there is increasing evidence of benefit in using statins to treat patients with non-ischaemic heart failure, it is not yet possible to recommend the routine use of these drugs in all heart failure patients, irrespective of the aetiology . . . . . . . . . . . . . . . . . . .
No takes yet. Share an insight, caveat, or question.
Leite‐Moreira et al. (2006) conducted an editorial in Heart failure. Statins (HMG-CoA reductase inhibitors) vs. Placebo was evaluated. Routine statin therapy cannot yet be recommended for all heart failure patients irrespective of aetiology due to small sample sizes and short follow-up in existing trials.
Synapse has enriched 10 related papers. Consider them for comparative context: